Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Psychological difficulties of ovarian cancer: an interview with Katherine Taylor

Ovarian cancer affects around 7000 thousand women in the UK every year and very sadly the outcomes are not great. A women dies every 2 hours of ovarian cancer. If I am diagnosed today, I’ve only got a 40% chance of being alive in 5 years’ time.

4 Mar 2016

Mapping family health history could drive patients to more timely screenings

Most doctors and nurses review a patient's family history to identify risk factors for heart disease and cancer, often through a paper checklist or brief interview.

4 Mar 2016

Differences in certain type of small protein may shed light on lung cancer risk in different races

Research from an investigator at Rutgers Cancer Institute of New Jersey and colleagues from the National Cancer Institute and other facilities, shows differences in a certain type of small protein vary by race and may contribute differently to the development of lung cancer in African Americans and European Americans.

3 Mar 2016

Oncimmune partners with Stroke Detection Plus to offer EarlyCDT-Lung test

Oncimmune, a leader in early cancer detection, today announced a partnership with Stroke Detection Plus® (SDP), a leading provider of cardiovascular and corporate wellness screenings in the US. Stroke Detection Plus and its wellness division, Health Gauge, will offer Oncimmune's EarlyCDT-Lung test to its clients which include large employers, unions and individuals.

3 Mar 2016

Researchers aim to develop gentler treatment that 'tricks' cancer cells

The most common treatments for cancer are radiation and chemotherapy. However they have side effects and also damage healthy tissues. Moreover, their effectiveness is limited when the cancer has spread through out the body. Researchers at the Niels Bohr Institute are therefore working to develop a gentler treatment that 'tricks' the cancer cells, which would absorb a cytotoxin and therefore be destroyed, while healthy cells would remain unaffected. The results are published in the scientific journal, Scientific Reports.

2 Mar 2016

Women struggling to find their voice: March 2016 ovarian cancer awareness month

Worrying new stats show almost 1 in 3 unable to talk about physical health issues with a doctor.

29 Feb 2016

Research unveils standard front-line treatment for advanced ovarian cancer

Research led by a Dignity Health St. Joseph's Hospital and Medical Center physician on ovarian cancer was published in the Feb. 24, 2016 issue of New England Journal of Medicine. The research was directed by Bradley J. Monk, M.D. and researchers at 12 other medical facilities around the nation.

27 Feb 2016

Investigating mechanism behind development of high-grade serous ovarian cancer

Rutgers Cancer Institute of New Jersey researcher Michael L. Gatza, PhD, has received a $747,000 Pathway to Independence Award (R00-CA166228) from the National Cancer Institute to explore the mechanism behind the development of a subtype of ovarian cancer known as high-grade serous ovarian cancer.

24 Feb 2016

Combining pain medicine with metal ions could destroy drug-resistant cancer cells

Fighting chemoresistant cancer remains a huge challenge that scientists are tackling from as many angles as they can. One alternative approach involves pairing two groups of compounds -- pain medicine and metal ions -- that have individually shown promise as anti-cancer agents. Scientists report in the ACS journal Inorganic Chemistry that combining the two led to new compounds that could destroy drug-resistant cancer cells and leave most normal cells alone in lab tests.

18 Feb 2016

Researchers reveal inherited genetic mutations associated with ovarian cancer risk

Previous research has established a link between genetic mutations in the BRCA1 and BRCA2 genes to an increased risk of developing ovarian, fallopian tube or peritoneal cancer in women.

11 Feb 2016

IDMC recommends continuation of PM1183 Phase III trial in platinum-resistant ovarian cancer patients

PharmaMar announced today that the Independent Data Monitoring Committee has notified the Company of its recommendation that the Phase III (CORAIL) trial currently under way with PM1183 in platinum-resistant ovarian cancer patients should continue without any changes.

8 Feb 2016

MabVax receives FDA authorization to initiate 89Zr-HuMab-5B1 Phase I trial in pancreatic cancer patients

MabVax Therapeutics Holdings, Inc., a clinical-stage oncology drug-development company, announces receipt of notice from the U.S. Food and Drug Administration authorizing initiation of a Phase I clinical trial with 89Zr-HuMab-5B1 as a new generation PET scan cancer imaging agent in patients with pancreatic cancer.

1 Feb 2016

Increased breastfeeding could save over 800000 children’s lives annually

Just 1 in 5 children in high-income countries are breastfed to 12 months, whilst only 1 in 3 children in low and middle-income countries are exclusively breastfed for the first 6 months.

30 Jan 2016

Costs of lower cognitive ability linked with not breastfeeding amount to over $300 billion each year

When countries, rich or poor, support breastfeeding through meaningful investments and programs, it has an impact on their bottom line and the health of women and children. The Lancet Breastfeeding Series, released today, finds that globally, the costs of lower cognitive ability associated with not breastfeeding amount to more than $300 billion each year, a figure comparable to the entire global pharmaceutical market.

29 Jan 2016

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Psychological difficulties of ovarian cancer: an interview with Katherine Taylor

Mapping family health history could drive patients to more timely screenings

Differences in certain type of small protein may shed light on lung cancer risk in different races

Oncimmune partners with Stroke Detection Plus to offer EarlyCDT-Lung test

Researchers aim to develop gentler treatment that 'tricks' cancer cells

Women struggling to find their voice: March 2016 ovarian cancer awareness month

Research unveils standard front-line treatment for advanced ovarian cancer

Investigating mechanism behind development of high-grade serous ovarian cancer

Combining pain medicine with metal ions could destroy drug-resistant cancer cells

Researchers reveal inherited genetic mutations associated with ovarian cancer risk

IDMC recommends continuation of PM1183 Phase III trial in platinum-resistant ovarian cancer patients

MabVax receives FDA authorization to initiate 89Zr-HuMab-5B1 Phase I trial in pancreatic cancer patients

Increased breastfeeding could save over 800000 children’s lives annually

Costs of lower cognitive ability linked with not breastfeeding amount to over $300 billion each year

Newly drafted consensus statement promotes widespread use of HPV vaccines to prevent cancer

AVAX announces results of Phase 1/2 OVAX study in patients with advanced ovarian cancer

ROCA Test now available in nine additional U.S. states for early detection of ovarian cancer

Oestrogen supplements could reduce dementia risk in women

Researchers identify biomarkers that may influence potential new drug design or alternative treatments of cancer

Women who carry inherited fault in BRIP1 gene at higher risk of developing ovarian cancer

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in